Acne: Asthma Drug Fails to Help Patients with Acne


Acne : Acne: Asthma Drug Fails to Help Patients with Acne	Homepage \| Add to Favorites

Recommended Sites

Related Links

Informative Articles

Acne Tips
Probiotics and Prebiotics Ask your health care provider about using probiotics and prebiotics. Probiotic supplements can assist with replenishing helpful bacterium in your digestive system that aid in effective processing and elimination of food,...

Finding The Right Facial Cleanser Product For You
If you are in the market for a facial cleanser product , you are certainly well aware of the amazing number of options from which to choose. A simple visit to your drug store results in an entire aisle dedicated to these potions that will clean...

Natural Beauty: What is it really?
Natural beauty is the ideal many people strive to achieve when they purchase make-up, creams, shampoos and other forms of cosmetics. But what really constitutes natural beauty, and how can it be achieved? Many consumers, in an attempt to cleanse,...

Some Natural Cures Made With Honey
Honey, especially mixed with cinnamon, can cure a multitude of ailments. Honey is produced in all parts of the world. Scientists of today believe honey can be used without any side affects for a number of diseases. Honey is sweet but if taken...

Treating Adult Acne With Anti-aging Moisturizers
Softening the skin and relieving wrinkles with anti-aging moisturizers is becoming a welcome and effective method of treating acne. To date there is a large and growing number of people, especially adult women, who have benefited from new...

Acne: Asthma Drug Fails to Help Patients with Acne

The asthma drug Zyflo fails to help patients with severe acne, according to a mid-stage trial carried out by the company Critical Therapeutics Inc. The drug, also known as zileuton, was neither better at controlling the number of inflammatory lesions than placebos under the company statistics.

Over the 12-week trial, patients treated with Zyflo had an average reduction of 11.5 inflammatory lesions. That compared with a reduction of 9.1 lesions in a group of other patients taking placebos - far short of achieving statistical significance.

Patients treated with placebo showed a reduction of 16.4 lesions in the placebo group, but patients treated with Zyflo showed a mean reduction in the total number of lesions of 25.3.

The company stated the medicine showed a trend of potential benefit to some patients although the drug failed the primary goal of the trial.

Linda Lennox, the company spokeswoman, told the company will probably conduct a larger trial testing the medicine as an acne treatment, using information gleaned from the small recent "proof of concept" trial.

The company based in Lexington, Massachusetts, said that it is continuing to analyze the data and is working with the investigators to further interpret the results.

Zyflo blocks an inflammation-causing enzyme called 5 lipoxygenase (5-LO). It was approved by U.S. regulators in 1996 for treating asthma patients 12 years of age and older. At the time, the drug was owned by Abbott Laboratories Inc., which sold it for a number of years before licensing it to Critical Therapeutics in late 2003.

Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution products information . Thanks for use this article in your website or ezine keeping a live link.

About the author:

Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution pr